Company News
Laurus Labs Acquires 60% Stake in Galenvs Sciences
Laurus Labs Board approved acquisition of 60% stake in Canada-based Galenvs Sciences Inc. for USD 3.75 million.
Galenvs is a contract research organization specializing in oligonucleotide synthesis an
